Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients Helle Krogh Johansen, Samuel.

Slides:

Advertisements

Similar presentations

Colonisation and infection of the paranasal sinuses in cystic fibrosis patients is accompanied by a reduced PMN response Helle Krogh Johansen, Kasper.

Advertisements

The effect of short-term, high-dose oral N-acetylcysteine treatment on oxidative stress markers in cystic fibrosis patients with chronic P. aeruginosa.

Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies Don B. Sanders, Huichuan J. Lai,

Secretory IgA as a diagnostic tool for Pseudomonas aeruginosa respiratory colonization Kasper Aanaes, Helle Krogh Johansen, Steen Seier Poulsen, Tacjana.

Development of resistance in Pseudomonas aeruginosa obtained from patients with cystic fibrosis at different times F.B. Spencker, L. Staber, T. Lietz,

Achromobacter species in cystic fibrosis: Cross-infection caused by indirect patient-to- patient contact C.R. Hansen, T. Pressler, W. Ridderberg, H.K.

Pseudomonas aeruginosa infection in cystic fibrosis caused by an epidemic metallo-β- lactamase-producing clone with a heterogeneous carbapenem resistance.

Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center

Colonisation and infection of the paranasal sinuses in cystic fibrosis patients is accompanied by a reduced PMN response Helle Krogh Johansen, Kasper.

Marked increase in incidence of Achromobacter xylosoxidans infections caused by sporadic acquisition from the environment Winnie Ridderberg, Karen E.M.

Is infection with hypermutable Pseudomonas aeruginosa clinically significant? Adi Auerbach, Eitan Kerem, Marc Victor Assous, Elie Picard, Maskit Bar-Meir

Evidence of transmission of verocytotoxin-producing Escherichia coli O111 from a cattle stable to a child E. Møller Nielsen, C. Jensen, D. Lau Baggesen

Secretory IgA as a diagnostic tool for Pseudomonas aeruginosa respiratory colonization Kasper Aanaes, Helle Krogh Johansen, Steen Seier Poulsen, Tacjana.

Risk factors for age at initial Pseudomonas acquisition in the cystic fibrosis epic observational cohort Margaret Rosenfeld, Julia Emerson, Sharon McNamara,

Early rise of anti-Pseudomonas antibodies and a mucoid phenotype of Pseudomonas aeruginosa are risk factors for development of chronic lung infection—A.

Acquisition of different carbapenem resistance mechanisms by an epidemic clonal lineage of Pseudomonas aeruginosa E. Edalucci, R. Spinelli, L. Dolzani,

Risk factors and outcome for colistin-resistant Acinetobacter nosocomialis bacteraemia in patients without previous colistin exposure Y.-C. Wang, Y.-T.

Meropenem in cystic fibrosis patients infected with resistant Pseudomonas aeruginosa or Burkholderia cepacia and with hypersensitivity to β-lactam antibiotics

Lack of evidence of increased risk of bacterial transmission during cystic fibrosis educational programmes Winnie Ridderberg, Camilla Andersen, Michael.

Epidemic Pseudomonas aeruginosa infection in patients with cystic fibrosis is not a risk factor for poor clinical Outcomes following lung transplantation

Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant.

Transmission of Pseudomonas aeruginosa in children with cystic fibrosis attending summer camps in The Netherlands R.W. Brimicombe, L. Dijkshoorn, T.J.K.

Laura Viviani, Baroukh M. Assael, Eitan Kerem

A longitudinal analysis of chronic MRSA and Pseudomonas aeruginosa co-infection in cystic fibrosis: A single-center study Maret L. Maliniak, Arlene A.

Cirrhosis and other liver disease in cystic fibrosis

Katelyn Krivchenia, Don Hayes, Joseph D. Tobias, Dmitry Tumin

C. Peña, M.A. Dominguez, M. Pujol, R. Verdaguer, F. Gudiol, J. Ariza

Increased serum concentration of G-CSF in cystic fibrosis patients with chronic Pseudomonas aeruginosa pneumonia P.Ø. Jensen, C. Moser, A. Kharazmi,

A. Oliver, A. Mena Clinical Microbiology and Infection

A cohort study of the Copenhagen CF Centre eradication strategy against Staphylococcus aureus in patients with CF Christina Schjellerup Dalbøge, Tacjana.

Lucas R. Hoffman, Hemantha D. Kulasekara, Julia Emerson, Laura S

Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study Christine Rønne.

D. Stevens, P.J. Oades, N. Armstrong, C.A. Williams

Claire J. Tipping, Rebecca L. Scholes, Narelle S. Cox

Molecular detection of an atypical, highly resistant, clonal Pseudomonas aeruginosa isolate in cystic fibrosis patients Deirdre Keating, Mary J. Crowe,

Decreased mucosal oxygen tension in the maxillary sinuses in patients with cystic fibrosis Kasper Aanaes, Lars Fledelius Rickelt, Helle Krogh Johansen,

Gerd Döring, Patrick Flume, Harry Heijerman, J. Stuart Elborn

Implementation of European standards of care for cystic fibrosis �� Control and treatment of infection J.S. Elborn, M. Hodson, C. Bertram Journal of.

P. aeruginosa in the paranasal sinuses and transplanted lungs have similar adaptive mutations as isolates from chronically infected CF lungs Oana Ciofu,

Pseudomonas aeruginosa infection in cystic fibrosis caused by an epidemic metallo-β- lactamase-producing clone with a heterogeneous carbapenem resistance.

A.H. Gifford Journal of Cystic Fibrosis

Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden Per Kristian Knudsen, Hanne.

Economic effects of an eradication protocol for first appearance of Pseudomonas aeruginosa in cystic fibrosis patients: 1995 vs. 2009 Yolanda P. Lillquist,

Effectiveness of inhaled tobramycin in eradicating Pseudomonas aeruginosa in children with cystic fibrosis Sanja Stanojevic, Valerie Waters, Joseph L.

E. Tschiedel, H. Grasemann, F. Ratjen Journal of Cystic Fibrosis

Comparison of antibiotic susceptibility patterns in Pseudomonas aeruginosa isolated from adult patients with cystic fibrosis (CF) with invasive Pseudomonas.

Colon Cancer in Cystic Fibrosis patients: Is this a growing problem?

Diagnostic multiplex PCR assay for the identification of the Liverpool, Midlands 1 and Manchester CF epidemic strains of Pseudomonas aeruginosa Joanne.

Stenotrophomonas maltophilia in cystic fibrosis: Improved detection by the use of selective agar and evaluation of antimicrobial resistance P. Goncalves-Vidigal,

Nasal polyposis in lung transplant recipients with cystic fibrosis

Novel concepts in evaluating antimicrobial therapy for bacterial lung infections in patients with cystic fibrosis Geraint B. Rogers, Lucas R. Hoffman,

Australian epidemic strain pseudomonas (AES-1) declines further in a cohort segregated cystic fibrosis clinic Amanda L. Griffiths, Danielle F. Wurzel,

Gender differences in treatment adherence among youth with cystic fibrosis: Development of a new questionnaire Joän M. Patterson, Melanie Wall, Jerica.

Segregation of children with CF diagnosed via newborn screening and acquisition of Pseudomonas aeruginosa Karen O. McKay, Peter J. Cooper, Peter P. van.

Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005 F.A. Millar, N.J. Simmonds, M.E. Hodson Journal.

Methicillin-resistant Staphylococcus saprophyticus in Sweden carries various types of staphylococcal cassette chromosome mec (SCCmec) B. Söderquist,

Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies Don B. Sanders, Huichuan J. Lai,

J.E. Spahr, R.B. Love, M. Francois, K. Radford, K.C. Meyer

Clonal spread of staphylococci among patients with peritonitis associated with continuous ambulatory peritoneal dialysis Tor Monsen, Carin Olofsson,

C. R. Hansen, T. Pressler, K. G. Nielsen, P. Ø. Jensen, T

Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group† H. Goossens Clinical.

D.F. Waterhouse, A.M. McLaughlin, C.G. Gallagher

CFTR modulators and pregnancy: Our work has only just begun

Marcus P. Kennedy, Raymond D. Coakley, Scott H. Donaldson, Robert M

Lutz Goldbeck, Sven Zerrer, Tim G. Schmitz Journal of Cystic Fibrosis

David Adeboyeku, Sandra Scott, Margaret E. Hodson

Increasing resistance of the Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa (Psa) to antibiotics in cystic fibrosis (CF)—A cause for concern?

B. Martha, D. Croisier, A. Fanton, K. Astruc, L. Piroth, F. Huet, P

Improved early diagnosis of Pseudomonas aeruginosa by real-time PCR to prevent chronic colonisation in a paediatric cystic fibrosis population Elaine.

Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience C.R.

Presentation transcript:

Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients Helle Krogh Johansen, Samuel M. Moskowitz, Oana Ciofu, Tacjana Pressler, Niels Høiby Journal of Cystic Fibrosis Volume 7, Issue 5, Pages 391-397 (September 2008) DOI: 10.1016/j.jcf.2008.02.003 Copyright © 2008 European Cystic Fibrosis Society Terms and Conditions

Fig. 1 Pulsed-field-gel-electrophoresis (PFGE) pattern of 12 colistin resistant non-mucoid Pseudomonas aeruginosa isolates from cluster 1 in the first outbreak (1995–1999), from 10 CF patients. The Spe restriction enzyme was used. Lane 1: molecular-weight standard, lane 2: pt #1, lane 3+4: pt #2 lane 5: pt #3, lane 6: pt #4, lane 7+8: pt #5, lane 9: pt #6, lane 10: pt #7, lane 11: pt #8, lane 12: pt #9 and lane 13: pt #10, K (control): PAO1. Journal of Cystic Fibrosis 2008 7, 391-397DOI: (10.1016/j.jcf.2008.02.003) Copyright © 2008 European Cystic Fibrosis Society Terms and Conditions

Fig. 2 The flowchart shows possible sources of transmission of colistin resistant Pseudomonas aeruginosa among the nine CF patients initially infected in 1995. Journal of Cystic Fibrosis 2008 7, 391-397DOI: (10.1016/j.jcf.2008.02.003) Copyright © 2008 European Cystic Fibrosis Society Terms and Conditions